TY - JOUR
T1 - The clinical usefulness of ESR, CRP, and disease duration in ankylosing spondylitis
T2 - the product of these acute-phase reactants and disease duration is associated with patient’s poor physical mobility
AU - Chen, Chun Hsiung
AU - Chen, Hung An
AU - Liao, Hsien Tzung
AU - Liu, Chin Hsiu
AU - Tsai, Chang Youh
AU - Chou, Chung Tei
PY - 2015/2/24
Y1 - 2015/2/24
N2 - We evaluated the clinical usefulness of ESR, CRP, and disease duration in ankylosing spondylitis (AS) disease severity. There were 156 Chinese AS patients included in Taiwan. Patients completed the questionnaires, containing demographic data, disease activity (BASDAI), functional status (BASFI), and patient’s global assessment (BASG). Meanwhile, patient’s physical mobility (BASMI) and acute-phase reactants, including ESR and CRP levels were measured. Receiver operating characteristic (ROC) plot analysis was used to evaluate the performance of ESR, CRP, and disease duration in the AS patients. ESR mildly correlated with BASFI (r = 0.176, p = 0.028) and disease duration (r = 0.214, p = 0.008), and moderately correlated with BASMI (r = 0.427, p
AB - We evaluated the clinical usefulness of ESR, CRP, and disease duration in ankylosing spondylitis (AS) disease severity. There were 156 Chinese AS patients included in Taiwan. Patients completed the questionnaires, containing demographic data, disease activity (BASDAI), functional status (BASFI), and patient’s global assessment (BASG). Meanwhile, patient’s physical mobility (BASMI) and acute-phase reactants, including ESR and CRP levels were measured. Receiver operating characteristic (ROC) plot analysis was used to evaluate the performance of ESR, CRP, and disease duration in the AS patients. ESR mildly correlated with BASFI (r = 0.176, p = 0.028) and disease duration (r = 0.214, p = 0.008), and moderately correlated with BASMI (r = 0.427, p
KW - Ankylosing spondylitis
KW - CRP
KW - Disease duration
KW - ESR
KW - Physical mobility
UR - http://www.scopus.com/inward/record.url?scp=84929839244&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84929839244&partnerID=8YFLogxK
U2 - 10.1007/s00296-015-3214-4
DO - 10.1007/s00296-015-3214-4
M3 - Article
C2 - 25708781
AN - SCOPUS:84929839244
SN - 0172-8172
VL - 35
SP - 1263
EP - 1267
JO - Rheumatology International
JF - Rheumatology International
IS - 7
ER -